The archive
137 stories from 60 issues. Filter by industry, type of news, date or company, and choose how much to read.
Type of news
Industry
6 stories
- 17 NovNewMETR finds AI can often tell when it is being safety-tested
Why it matters Safety tests that an AI can recognise as tests prove less about how it behaves in real deployments, so discount such results.
Impact Safety test results lose weight when models recognise tests as fake setups.
What happened METR ran AI investigator agents against capability and alignment tests, and the agents increasingly told the two kinds apart. They spotted alignment tests because the environment looked fake and the task looked like a honeypot built to trap an AI agent.
- 4 NovNew
Launch
Google's AI helper cuts a days-long drug design cycle to about an hourWhy it matters Drug discovery teams can cut one design-and-data cycle from several days to about an hour, based on Google DeepMind's lung cancer demo.
Impact Drug design cycles shrink from days to about an hour with AI agents.
What happened Google DeepMind added a set of Cheminformatics Skills to its Google Antigravity workspace. In a lung cancer demo, an AI agent screened a large pool of molecules, ran matched molecular pair analysis and proposed new ring-shaped candidates with synthesis routes in about an hour, versus days per cycle.
- 27 OctNewOpenAI shares AI results on three science problems for outside researchers to check
Impact Labs can check and extend AI-generated science results using OpenAI's published verification methods.
What happened OpenAI has published what its AI produced on three open science problems: the Kakeya conjecture in mathematics, the Exponential Time Hypothesis in computer science, and quantum chromodynamics in physics. It also describes how outside researchers can check the work and extend it.
- 16 OctNew
Programme
OpenAI is giving university biology labs sponsored access to its science AIWhy it matters Life sciences startups now compete for academic talent and partnerships with labs that get OpenAI's GPT-Rosalind through a sponsored plan.
Impact Qualifying university biology labs get funded access to GPT-Rosalind and supporting tools.
What happened OpenAI launched the Rosalind Academic Plan, which gives qualifying university research labs funded use of GPT-Rosalind plus supporting tools for life sciences work.
- 16 OctNewGoogle's AI platform helped scientists find a possible new antibiotic candidate, still untested in labs
Why it matters Drug discovery teams can run a multi-database target search in one agent session, but the lead is only predicted, not lab-confirmed.
Impact Agent platforms can scan protein databases for antibiotic leads, still awaiting lab validation.
What happened Google DeepMind says biologists used its Antigravity agent platform to search millions of uncharacterized UniProt proteins with the ProtNLM model. They found one antimicrobial peptide candidate with predicted activity against respiratory pathogens, now in wet-lab validation.
- 7 OctNewOpenAI reports its internal model made progress on unsolved maths problems
Why it matters OpenAI's unreleased model is producing checkable maths results, so expect that reasoning strength in products you can buy later.
Impact Machine-checked proofs of open maths problems show frontier models contributing verifiable results to research.
What happened OpenAI released findings on unsolved maths problems worked by one of its internal frontier models. Machine-checked Lean versions of the proofs, plus supporting write-ups, are posted on GitHub.